Compass Therapeutics, Inc. (CMPX)

Compass Therapeutics Statistics

Total Valuation

CMPX has a market cap or net worth of $1.00 billion. The enterprise value is $834.63 million.

Market Cap	1.00B
Enterprise Value	834.63M

Important Dates

The last earnings date was Thursday, March 5, 2026, before market open.

Earnings Date	Mar 5, 2026
Ex-Dividend Date	n/a

Share Statistics

CMPX has 180.09 million shares outstanding. The number of shares has increased by 14.78% in one year.

Current Share Class	180.09M
Shares Outstanding	180.09M
Shares Change (YoY)	+14.78%
Shares Change (QoQ)	+9.52%
Owned by Insiders (%)	8.04%
Owned by Institutions (%)	70.17%
Float	118.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.91
P/TBV Ratio	5.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.02, with a Debt / Equity ratio of 0.05.

Current Ratio	15.02
Quick Ratio	14.96
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -41.29% and return on invested capital (ROIC) is -26.90%.

Return on Equity (ROE)	-41.29%
Return on Assets (ROA)	-25.29%
Return on Invested Capital (ROIC)	-26.90%
Return on Capital Employed (ROCE)	-35.42%
Weighted Average Cost of Capital (WACC)	11.25%
Revenue Per Employee	n/a
Profits Per Employee	-$1.90M
Employee Count	35
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +107.06% in the last 52 weeks. The beta is 1.29, so CMPX's price volatility has been higher than the market average.

Beta (5Y)	1.29
52-Week Price Change	+107.06%
50-Day Moving Average	5.87
200-Day Moving Average	4.16
Relative Strength Index (RSI)	41.82
Average Volume (20 Days)	2,024,601

Short Selling Information

The latest short interest is 22.36 million, so 12.42% of the outstanding shares have been sold short.

Short Interest	22.36M
Short Previous Month	21.93M
Short % of Shares Out	12.42%
Short % of Float	18.82%
Short Ratio (days to cover)	9.33

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-72.84M
Pretax Income	-66.49M
Net Income	-66.49M
EBITDA	-72.56M
EBIT	-72.84M
Earnings Per Share (EPS)	-$0.42

Balance Sheet

The company has $208.91 million in cash and $9.83 million in debt, with a net cash position of $199.08 million or $1.11 per share.

Cash & Cash Equivalents	208.91M
Total Debt	9.83M
Net Cash	199.08M
Net Cash Per Share	$1.11
Equity (Book Value)	196.79M
Book Value Per Share	1.10
Working Capital	195.85M

Cash Flow

In the last 12 months, operating cash flow was -$49.14 million and capital expenditures -$25,000, giving a free cash flow of -$49.17 million.

Operating Cash Flow	-49.14M
Capital Expenditures	-25,000
Free Cash Flow	-49.17M
FCF Per Share	-$0.27

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CMPX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.78%
Shareholder Yield	-14.78%
Earnings Yield	-6.43%
FCF Yield	-4.76%

Analyst Forecast

The average price target for CMPX is $14.43, which is 159.07% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.43
Price Target Difference	159.07%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2